Metraipolis › archive › dc_430eb878ae38

EZH2-Associated Hypermethylated Gene Signature Predicts Immunotherapy Response and Implicates DUSP5 in Tumor-Immune Regulation in Triple-Negative Breast Cancer — Europe PMC PMID:42192966

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42192966
DOI
10.3390/cancers18101606
License (as archived)
solo-consultazione
Archived
2026-11-02T06:50:52.002Z
SHA-256 of the archived text
dbe390ad78ef31f8fd6ffc5f153ff7afd9975b9533cb63fa04ada8b7b0b1ab7e
Stable URL of this page
https://metraipolis.com/documento/dc_430eb878ae38

How to cite

EZH2-Associated Hypermethylated Gene Signature Predicts Immunotherapy Response and Implicates DUSP5 in Tumor-Immune Regulation in Triple-Negative Breast Cancer — Europe PMC PMID:42192966 — Europe PMC (en), https://europepmc.org/article/MED/42192966 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_430eb878ae38 (Metraipolis archive dc_430eb878ae38, sha256 dbe390ad78ef31f8fd6ffc5f153ff7afd9975b9533cb63fa04ada8b7b0b1ab7e)
BibTeX
@misc{dc430eb878ae38,
  title = {EZH2-Associated Hypermethylated Gene Signature Predicts Immunotherapy Response and Implicates DUSP5 in Tumor-Immune Regulation in Triple-Negative Breast Cancer — Europe PMC PMID:42192966},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42192966},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_430eb878ae38; sha256 dbe390ad78ef31f8fd6ffc5f153ff7afd9975b9533cb63fa04ada8b7b0b1ab7e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42192966. Agents can read the archived copy with the MCP tool read_document.